ICD-10 Coding for Ependymoma(C71.5, C72.0)
Complete ICD-10-CM coding and documentation guide for Ependymoma. Includes clinical validation requirements, documentation requirements, and coding pitfalls.
Also known as:
Related ICD-10 Code Ranges
Complete code families applicable to Ependymoma
Code Comparison: When to Use Each Code
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C71.5 | Malignant neoplasm of cerebral ventricle | Use for confirmed malignant ependymomas located in the cerebral ventricle. |
|
| C72.0 | Malignant neoplasm of spinal cord | Use for confirmed malignant ependymomas located in the spinal cord. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information: ICD-10 code for ependymoma
Essential facts and insights about Ependymoma
Primary ICD-10-CM Codes for ependymoma
Decision Criteria
clinical Criteria
- Confirmed malignancy via histology
Applicable To
- Supratentorial ependymoma
- Intraventricular ependymoma
Excludes
- Benign ependymoma (D33.2)
Clinical Validation Requirements
- Histological confirmation of ependymoma
- MRI showing supratentorial mass
Code-Specific Risks
- Incorrectly coding benign tumors as malignant.
Coding Notes
- Ensure histological confirmation of malignancy before coding.
C72.0 - Malignant neoplasm of spinal cord
Use for confirmed malignant ependymomas located in the spinal cord.
Applicable To
- Spinal ependymoma
- Myxopapillary ependymoma
Excludes
- Benign spinal tumors (D33.4)
Clinical Validation Requirements
- Histological confirmation of spinal ependymoma
- MRI showing spinal cord mass
Coding Notes
Ensure histological confirmation of malignancy before coding.
Documentation & Coding Risks
Avoid these common documentation and coding issues when documenting Ependymoma to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code C71.5.
Impact
Clinical: Inaccurate treatment planning., Regulatory: Non-compliance with coding updates., Financial: Potential reimbursement issues.
Mitigation Strategy
Include molecular testing results in reports., Cross-check with histological findings.
Impact
Reimbursement: Incorrect reimbursement rates., Compliance: Non-compliance with coding standards., Data Quality: Inaccurate clinical data.
Mitigation Strategy
Verify histological findings before assigning codes.
Impact
Failure to document molecular findings can lead to audit issues.
Mitigation Strategy
Ensure all histological and molecular data are included in reports.
Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.
Frequently Asked Questions
Common questions about ICD-10 coding for Ependymoma, with expert answers to help guide accurate code selection and documentation.
Documentation Templates for Ependymoma
Use these documentation templates to ensure complete and accurate documentation for Ependymoma. These templates include all required elements for proper coding and billing.
Histological confirmation of ependymoma
Specialty: PathologyRequired Elements
- Tumor location
- Histological grade
- Molecular findings
Example Documentation
Examples: Poor vs. Good Documentation
Poor Documentation Example
Good Documentation Example
Explanation
Need help with ICD-10 coding for Ependymoma? Ask your questions below.